MedLife has announced the first preliminary results from its genomics study, part of the Longevity100+ programme, which aims to explore the role of genetic testing in preventive medicine. The findings are based on the analysis of more than 3,000 genetic tests processed so far. The analysis indicates significant correlations between identified genetic predispositions, patients’ medical history, and laboratory test results. The results represent an initial step toward validating the use of

Tag-uri: Medlife